Nociceptive circling and naloxoneRABINOWITZ, R; SHLESINGER, N; KORCZYN, A. D et al.Pharmacological research communications. 1983, Vol 15, Num 10, pp 963-967, issn 0031-6989Article

Failure of metergoline to antagonize naloxone induced cortisol rise in manCHODERA, P; COIRO, V; VOLPI, R et al.Hormone and metabolic research. 1984, Vol 16, Num 2, issn 0018-5043, 109Article

Antagonists Induce a Conformational Change in clAP1 That Promotes AutoubiquitinationDUEBER, Erin C; SCHOEFFLER, Allyn J; WALLWEBER, Heidi J. A et al.Science (Washington, D.C.). 2011, Vol 334, Num 6054, pp 376-380, issn 0036-8075, 5 p.Article

Desacetyl-1-nantradol: a selective prostaglandin antagonistNORNE, W. V.Prostaglandins leukotrienes and medicine. 1984, Vol 15, Num 1, pp 129-136, issn 0262-1746Article

Nifedipine does not alter metacholine-induced bronchial reactivityMATTHEWS, J. I; RICHEY, H. M. III; EWALD, J. W. JR et al.Annals of allergy. 1984, Vol 53, Num 6, pp 462-467, issn 0003-4738Article

Inhibitors of prostaglandin synthesis or cathepsin B prevent muscle wasting due to sepsis in the ratRUFF, R. L; SECRIST, D.The Journal of clinical investigation. 1984, Vol 73, Num 5, pp 1483-1486, issn 0021-9738Article

Inhibitory effect of calmodulin inhibitors on palytoxin-induced K⁺ release from rabbit erythrocytesNAGASE, H; OZAKI, H; URAKAWA, N et al.FEBS letters. 1984, Vol 178, Num 1, pp 44-46, issn 0014-5793Article

Lipophile Naphthole und 1,4-Naphthochinone als Inhibitoren der Prostaglandinsynthese. VI Mitt.: Untersuchungen an 1,4-Naphthochichen = Naphtols lipophiles et naphtoquinones-1,4 comme inhibiteurs de la biosynthèse des prostaglandines. VI. Etude des naphtoquinone-1,4 = Lipophilic naphthols and 1,4-naphtoquinones as inhibitors of the prostaglandin synthesis. VI: Investigations of 1,4-naphthoquinonesWURM, G; BAUMANN, J; GERES, U et al.Arzneimittel-Forschung. 1984, Vol 34, Num 6, pp 652-658, issn 0004-4172Article

Phenoxybenzamine-induced inhibition of cirazoline pressor responses in pithed rats pretreated with organic or inorganic calcium entry blocking drugsBOU, J; MASSINGHAM, R.European journal of pharmacology. 1984, Vol 102, Num 3-4, pp 535-539, issn 0014-2999Article

Reversal of acute experimental cerebral vasospasm by calcium antagonism with verapamilLEBLANC, R; FEINDEL, W; YAMAMOTO, L et al.Canadian journal of neurological sciences. 1984, Vol 11, Num 1, pp 42-47, issn 0317-1671Article

Calcium antagonists and endocrine status: lack of effect of oral verapamil on pituitary-testicular and pituitary-thyroid functionSEMPLE, C. G; THOMSON, J. A; BEASTALL, G. H et al.British journal of clinical pharmacology. 1984, Vol 17, Num 2, pp 179-182, issn 0306-5251Article

Les antimorphiniques = AntimorphinicsMONTASTRUC, J.-L.La Revue du praticien (Paris). 1983, Vol 33, Num 7, pp 293-305, issn 0035-2640Article

Calcium blocking properties of piprofurolPOURRIAS, B; HUERTA, F; SANTAMARIA, R et al.Archives internationales de pharmacodynamie et de thérapie. 1985, Vol 284, Num 2, pp 223-239, issn 0003-9780Article

Effects of thioridazine and its metabolites on dopaminergic function: drug metabolism as a determinant of the antidopaminergic actions of thioridazineKILTS, C. D; KNIGHT, D. L; MAILMAN, R. B et al.The Journal of pharmacology and experimental therapeutics. 1984, Vol 231, Num 2, pp 334-342, issn 0022-3565Article

N-1-Alkyl-2-oxo-2-aryl amides as novel antagonists of the TRPA1 receptorVALLIN, Karl S. A; STERKY, Karin J; SEHGELMEBLE, Fernando W et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 17, pp 5485-5492, issn 0960-894X, 8 p.Article

Kinetic versus allosteric mechanisms to explain insurmountable antagonism and delayed ligand dissociationVAUQUELIN, Georges; SZCZUKA, Anna.Neurochemistry international. 2007, Vol 51, Num 5, pp 254-260, issn 0197-0186, 7 p.Conference Paper

Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitorsSYDER, Andrew J; LEE, Haekyung; MCKELVY, Jeffrey et al.Journal of hepatology. 2011, Vol 54, Num 1, pp 48-55, issn 0168-8278, 8 p.Article

Identification of a novel dual E- and N-cadherin antagonistDEVEMY, Emmanuelle; BLASCHUK, Orest W.Peptides (New York, NY. 1980). 2009, Vol 30, Num 8, pp 1539-1547, issn 0196-9781, 9 p.Article

Discovery of potent and specific CXCR3 antagonistsXIAOQI CHEN; MIHALIC, Jeff; HENNE, Kirk et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 1, pp 357-362, issn 0960-894X, 6 p.Article

Exiguobacterium acetylicum strain 1P (MTCC 8707) a novel bacterial antagonist from the North Western Indian HimalayasSELVAKUMAR, Govindan; JOSHI, Piyush; NAZIM, Sehar et al.World journal of microbiology & biotechnology. 2009, Vol 25, Num 1, pp 131-137, issn 0959-3993, 7 p.Article

Implication de la chimiokine CCL2 dans la transmission de l'information nociceptive = CCL2 chemokine and transmission of nociceptive informationMELIK-PARSADANIANTZ, Stéphane.Biologie aujourd'hui. 2010, Vol 204, Num 4, pp 301-309, issn 2105-0678, 9 p.Conference Paper

Effects of calcium channel blockers and a calmodulin antagonist on contractions of guinea pig airwaysBURKA, J. F.European journal of pharmacology. 1984, Vol 99, Num 4, pp 257-268, issn 0014-2999Article

The peripheral narcotic antagonist N-allyl levallorphan-bromide (CM 32191) selectively prevents morphine antipropulsive action and buprenorphine in-vivo binding in the rat intestineBIANCHI, G; FIOCCHI, R; PERACCHIA, F et al.Journal of pharmacy and pharmacology. 1984, Vol 36, Num 5, pp 326-330, issn 0022-3573Article

Drug inhibition of mast cell secretionLUDOWYKE, R; LAGUNOFF, D.Progress in drug research. 1985, Vol 29, pp 277-301, issn 0071-786XArticle

International symposium on ion channels and calcium antagonistsZhōngguó yàoli xuébào. 1992, Vol 13, Num 1, issn 0253-9756, 72 p.Conference Paper